Are ovarian cancer stem cells the target for innovative immunotherapy? – Dove Medical Press
|
Are ovarian cancer stem cells the target for innovative immunotherapy?
Dove Medical Press Ovarian cancer, the most malignant gynecological cancer, has consistent pathology behavior with CSC model, which suggests that therapies based on ovarian cancer stem cells (OCSCs) can gain a more successful prognosis. Much evidence has proved that … |
